This announcement is a separate document:
艾迪药业关于艾诺韦林原料药获得上市申请批准通知书的自愿性披露公告
Voluntary Disclosure Announcement of Jiangsu Aidea Pharmaceutical regarding the Approval Notification of the Listing Application for Active Pharmaceutical Ingredient of Enolivir.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.